Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patientsEvangelos D. Michelakis, Martin R. Wilkins, Adam Kinnaird et al.|Science Translational Medicine|2017Cited by 311
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial HypertensionGerhard‐Paul Diller, John Wharton, Sven van Eijl et al.|Circulation|2008Cited by 225
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J. Rhodes, Martin R. Wilkins, Pavandeep Ghataorhe et al.|Circulation|2016Cited by 214
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Taco W. Kuijpers, Marta Bleda et al.|Circulation|2017Cited by 144
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertensionMark Toshner, Paul A. Corris, Colin Church et al.|European Respiratory Journal|2021Cited by 89